Journal of Clinical Investigation · 2000 · 99 citations · 54 references
Life SciencesCell BiologyApoptosisCell SignalingLactationApoptosis In DevelopmentApoptosis RegulationApoptotic SignalingMammary Epithelial Cell BiologyMammary Gland DevelopmentMammary Gland InvolutionEpithelial ApoptosisFas LigandFas Ligand-mediated ApoptosisFas Receptor SignalingFas-associated Death Domain ProteinMammary Gland HistologyMammary Gland MorphogenesisMammary Gland Morphology
Mammary involution is associated with degeneration of the alveolar structure and programmed cell death of mammary epithelial cells. In this study, we evaluated the expression of Fas and Fas ligand (FasL) in the mammary gland tissue and their possible role in the induction of apoptosis of mammary cells. FasL-positive cells were observed in normal mammary epithelium from pregnant and lactating mice, but not in nonpregnant/virgin mouse mammary tissue. Fas expression was observed in epithelial and stromal cells in nonpregnant mice but was absent during pregnancy. At day 1 after weaning, high levels of both Fas and FasL proteins and caspase 3 were observed and coincided with the appearance of apoptotic cells in ducts and glands. During the same period, no apoptotic cells were found in the Fas-deficient (MRL/lpr) and FasL-deficient (C3H/gld) mice. Increase in Fas and FasL protein was demonstrated in human (MCF10A) and mouse (HC-11) mammary epithelial cells after incubation in hormone-deprived media, before apoptosis was detected. These results suggest that the Fas-FasL interaction plays an important role in the normal remodeling of mammary tissue. Furthermore, this autocrine induction of apoptosis may prevent accumulation of cells with mutations and subsequent neoplastic development. Failure of the Fas/FasL signal could contribute to tumor development.
54
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
Naoto Itoh, Shin Yonehara, Ai Ishii et al. · Cell · 1991 · 2.8K citations
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Thomas S. Griffith, Thomas Brunner, Sharon M. Fletcher et al. · Science · 1995 · 2K citations
Medicine, Immunology, Ophthalmology +17
Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand
Tomohiro Takahashi, Masato Tanaka, Camllynn I. Brannan et al. · Cell · 1994 · 1.5K citations
Life Sciences, Immunology, Pathology +12
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Michael Hahne, Donata Rimoldi, Michael Schröter et al. · Science · 1996 · 1.3K citations
Life Sciences, Immunology, Oncology +17